POSTER SESSION IV
Tuesday, March 27, 2007 — 1:00 PM - 4:30 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
LIVER AND PANCREAS
Poster#
Title and Authors
Itinerary Planner
160
Value of Glypican-3 Immunostaining in the Diagnosis of Hepatocellular Carcinoma on Needle Biopsy
(1266)
F Anatelli, ST Chuang, XJ Yang, HL Wang - Washington University School of Medicine, St. Louis, MO; Northwestern University Feinberg School of Medicine, Chicago, IL
Evaluation of the Diagnostic Value of Glypican 3 for Hepatocellular Carcinoma in Liver Needle Biopsies
(1288)
M Hishinuma, N Fukushima, J Shibahara, S Ota, T Kodama, H Aburatani, M Fukayama - Graduate School of Medicine, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan; Research Center for Advanced Science and Technology, The University of Tokyo, Komaba, Meguro-ku, Tokyo, Japan
Glypican-3 Expression Has Low Sensitivity for the Diagnosis of Extremely Well-Differentiated Variants of Hepatocellular Carcinoma and Fibrolamellar Carcinoma
(1340)
N Shafizadeh, L Ferrell, S Kakar - VA and UCSF Medical Center, San Francisco, CA
Fibrolamellar Carcinomas but Not Typical Hepatocellular Carcinomas Are Positive for Anterior Gradient-2
(1317)
STL Micchelli, M Torbenson - The Johns Hopkins School of Medicine, Baltimore, MD
Chromosomal Changes in Fibrolamellar Hepatocellular Carcinoma Determined by Array-Based Comparative Genomic Hybridization
(1355)
A Yabes, L Burgart, D Jain, S Kakar - UCSF Medical Center, San Francisco, CA; Abbott NW Hosp, Minneapolis, MN; Yale University, New Haven, CT
p27, Cks1, Skp2 and PTEN Expression in Hepatocellular Carcinoma
(1357)
V Zolota, V Tzelepi, A Liava, N Pagoni, T Petsas, C Karatza, CD Scopa, AC Tsamandas - University of Patras School of Medicine, Patras, Greece
Inhibitiory Effect of Celecoxib, a Nonsteroidal Anti-Inflammatory Drug, on Spontaneously Developed Hepatocellular Carcinomas in AOX Null Mice
(1271)
W Cao, W Wiseman, P Kashireddy, MS Rao - Northwestern University, Chicago, IL
Over-Expression of Wnt Signaling Pathway Member Pygo in Hepatocellular Carcinoma
(1296)
R Kannangai, P Vivekanandan, M Torbenson - Johns Hopkins University School of Medicine, Baltimore, MD
Investigation of a Novel Oncogenic Pathway in Hepatocellular Carcinoma
(1283)
MF Gayyed, J Dong, M Torbenson, A Klein, DJ Pan, RA Anders - Johns Hopkins School of Medicine, Baltimore, MD
Synergistic Effect of Ciprofibrate, a PPAR a Agonist, and Choline Deficient Diet in Hepatocarcinogenesis in Rats
(1299)
P Kashireddy, WQ Cao, MS Rao - Feinberg School of Medicine, NU, Chicago, IL
Immunohistochemical Evidence of Different Progenitor Cell Types in Human Hepatocellular Carcinoma: What Is the Significance?
(1270)
LK Campbell, S Takemoto, EM Brunt - Saint Louis University, St. Louis, MO
Histopathologic Features of Radiologically Underdiagnosed Hepatocellular Carcinoma
(1287)
BS Henninger, EW Johnson, PE Swanson, MP Upton, MM Yeh - University of Washington, Seattle, WA
Clinical Pathologic Review of 106 Failed Liver Grafts Treated with Retransplantion
(1320)
RE Nakhleh, M Krishna, PV Genco, C Panjala, AP Keaveny - Mayo Clinic Jacksonville, Jacksonville, FL
Unexplained Morphologic Hepatitis and Fibrosis in Baseline Donor Liver Biopsies: Follow-Up Histologic Findings and Clinical Outcome
(1308)
M Krishna, MS Ghabril, RC Dickson, RE Nakhleh - Mayo Clinic, Jacksonville, FL
Centrilobular Hepatitis in Pediatric Liver Transplants
(1265)
SC Abraham, AM Krasinskas, TT Wu - Mayo Clinic, Rochester, MN; Univ of Pittsburgh, Pittsburgh, PA
C4d as a Marker for Acute Rejection Following Liver Transplantation — A TMA Application
(1337)
DF Schaeffer, SW Chung, CH Scudamore, UP Steinbrecher, DA Owen - University of British Columbia, Vancouver, BC, Canada
Recurrent Steatosis Following Liver Transplant for Non-Alcoholic Steatohepatitis or Cryptogenic Cirrhosis; Histomorphologic and Clinical Follow-Up in 231 Patients
(1329)
JN Punia, VV Shah, MA Sherbondy - Henry Ford Hospital, Detroit, MI
Histologic Predictors for Recurrence of Primary Sclerosing Cholangitis in Liver Allografts
(1319)
EM Naar, J Alexander, K Kowdley, PE Swanson, MP Upton, MM Yeh - University of Washington, Seattle, WA
Specific Definitions of Fatty Change in Transplant Donor Liver Biopsies Increase Interobserver Agreement
(1343)
VO Tan, LW Browne, LD Ferrell - UCSF, San Francisco, CA
Expression of CXCR3 and IP-10 in Recurrent Hepatitis C Following Liver Transplantation
(1327)
LM Petrovic, L Chiriboga, M Zeremski, Q Liu, AH Talal - New York University School of Medicine, New York, NY; Cornell University, New York, NY
One-Year Interim Report on the HCV-3 Trial: Favorable Histologic ACR Rates in Steroid-Free Immunosuppression Regimen
(1322)
GJ Netto, D Watkins, W Niklinsk, F Sharkey, N Jhala, S Sharma, C Coreless, T Colby, G Klintmalm, The HCV3 Trial Group - Johns Hopkins Univ, Baltimore; Baylor Univ. Med. Ctr, Dallas; UT San Antonio; Emory Univ; Univ. of Cincinnati; Univ. of Alabama at Birmingham; Oregon Health & Science Univ; Mayo Clinic, Scottsdale
Viral Eradication of Hepatitis C Virus after Successful Therapy May Be Associated with Long-Term Histologic Persistence of Chronic Inflammation on Liver Biopsies in Liver Transplant Patients
(1345)
VO Tan, N Terrault, S Feng, LD Ferrell - UCSF, San Francisco, CA
button next to any title to add to Itinerary Planner...
Add
